The role of surgery in high-grade glioma - Is surgical resection justified? A review of the current knowledge

Annals of the Academy of Medicine Singapore

Volumn 36, Issue 5, 2007, Pages 358-363

  Pang, Boon Chuan ^a   Wan, Wei Hwang ^a   Lee, Cheng Kiang ^a   Khu, Kathleen Joy ^a   Ng, Wai Hoe ^a  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

Author keywords

Astrocytoma; Brain tumour; Glioma; Outcome; Resection; Surgery; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; DEXAMETHASONE;

CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COCHRANE LIBRARY; CONSCIOUS SEDATION; CONTROLLED CLINICAL TRIAL; CRANIOTOMY; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLIOBLASTOMA; GLIOMA; HUMAN; MEDICAL LITERATURE; MEDLINE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; TUMOR RECURRENCE;

EID: 34547203946     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Bennett H, Godlee RJ. Excision of a tumour from the brain. Lancet 1884;2:1090-1.
2. Avgeropoulos NG, Batchelor TT. New treatment strategies for malignant gliomas. Oncologist 1999;4:209-24.
3. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998;88:1-10.
4. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Nelson DF, et al. Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 1992;12:219-27.
5. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95: 190-8.
6. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002;20:1375-82.
7. Mallory FB. Principles of Pathologic Histology. Philedelphia: WB Saunders, 1925.
8. Ammirati M, Vick N, Liao YL, Ciric I, Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 1987;21:201-6.
9. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 1998;42:1044-55.
10. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kail BA, Kispert DB. Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62:450-9.
11. Dandy WE. Removal of right cerebral hemisphere for certain tumors with hemiplegia. JAMA 1928;90:823-5.
12. Gardner WE. Removal of the right cerebral hemisphere for infiltrating glioma. Arch Neurol Psychiatry 1932;67:787-9.
13. Rowe SN. Mental changes following the removal of the right cerebral hemisphere for brain tumor. Am J Psychiatry 1937;94:605-14.
14. Hillier WF Jr. Total left cerebral hemispherectomy for malignant glioma. Neurology 1954;4:718-21.
15. Burklund CW, Smith A. Language and the cerebral hemispheres. Observations of verbal and nonverbal responses during 18 months following left ("dominant") hemispherectomy. Neurology 1977;27: 627-33.
16. Sneed PK, Gutin PH, Larson DA, Malec MK, Phillips TL, Prados MD, et al. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 1994;29:719-27.
17. Nazzaro JM, Neuwelt EA. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 1990;73:331-44.
18. Quigley MR, Maroon JC. The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 1991;29:385-8.
19. Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 1999;42:227-31.
20. Grant R, Metcalfe SE. Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev 2005;2:CD002034.
21. Buckner JC. Factors influencing survival in high-grade gliomas. Semin Oncol 2003;30(6 Suppl 19):10-4.
22. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003;99:467-73.
23. Proescholdt MA, Macher C, Woertgen C, Brawanski A. Level of evidence in the literature concerning brain tumor resection. Clin Neurol Neurosurg 2005;107:95-8.
24. Bucci MK, Maity A, Janss AJ, Belasco JB, Fisher MJ, Tochner ZA, et al. Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era. Cancer 2004;101:817-24.
25. Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 2005;57:495-504.
26. Schneider JP, Trantakis C, Rubach M, Schulz T, Dietrich J, Winkler D, et al. Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme - a quantitative radiological analysis. Neuroradiology 2005;47:489-500.
27. Stark AM, Nabavi A, Mehdorn HM, Blomer U. Glioblastoma multiforme - report of 267 cases treated at a single institution. Surg Neurol 2005;63:162-9.
28. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
29. Hentschel SJ, Lang FF. Current surgical management of glioblastoma. Cancer J 2003;9:113-25.
30. Whittle IR, Pringle AM, Taylor R. Effects of resective surgery for left-sided intracranial tumours on language function: a prospective study. Lancet 1998;351:1014-8.
31. Mitchell P, Ellison DW, Mendelow AD. Surgery for malignant gliomas: mechanistic reasoning and slippery statistics. Lancet Neurol 2005;4: 413-22.
32. Ng WH, Wan GQ, Too HP. Higher glioblastoma tumour burden confers resistance to chemotherapeutic agent - in vitro evidence. J Clin Neurosci 2007;14:261-6.
33. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002;359:1011-8.
34. Sawaya R. Extent of resection in malignant gliomas: a critical summary. J Neurooncol 1999;42:303-5.
35. Jackson RJ, Fuller GN,Abi-Said D, Lang FF, Gokaslan ZL, Shi WM, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-oncol 2001;3:193-200.
36. Muacevic A, Kreth FW. Quality-adjusted survival after tumor resection and/or radiation therapy for elderly patients with glioblastoma multiforme. J Neurol 2003;250:561-8.
37. Mueller, WM, Yetkin FZ, Hammeke TA, Morris GL III, Swanson SJ, Reichert K, et al. Functional magnetic resonance imaging mapping of the motor cortex in patients with cerebral tumors. Neurosurgery 1996;39: 515-20.
38. Nimsky C, Ganslandt O, Buchfelder M, Fahlbusch R. Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI. Neurol Res 2006;28: 482-7.
39. Oh DS, Black PM. A low-field intraoperative MRI system for glioma surgery: is it worthwhile? Neurosurg Clin N Am 2005;16:135-41.
40. Meyer, FB, Bates LM, Goerss SJ, Friedman JA, Windschitl WL, Duffy JR, et al. Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain. Mayo Clin Proc 2001;76:677-87.